Our previous study found that: [1] EFNB2 overexpression significantly promoted post-metastatic growth of CRC LM; [2] blocking EFNB2 forward signaling, but not reverse signaling, inhibited the promoting effect of EFNB2 overexpression on CRC LM. The gene discussed is EFNB2; the disease is colorectal carcinoma.